newsfilter
← Latest News
PR Newswire·

Emmaus Life Sciences Receives U.A.E. Marketing Authorization for Endari®

TORRANCE, Calif., March 23, 2022 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX:EMMA) a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today announced the approval of its application for marketing auth